Literature DB >> 19634024

Bolus compared with continuous infusion of microbubble contrast agent using real-time contrast harmonic imaging ultrasound in breast tumors.

A Saracco1, P Aspelin, K Leifland, R Themudo, B Wilczek, R Axelsson.   

Abstract

BACKGROUND: Contrast-enhanced ultrasound (CEUS) has gained interest because of its ability to gather vascular information in various organs. There is still a matter of debate concerning its value in breast lesions. The method of choice on how to administer the contrast agent varies depending on the organ to be studied. Infusion of microbubbles is used in echocardiography, while bolus administration is the preferred technique for abdominal organs.
PURPOSE: To compare-in equal doses-bolus versus continuous infusion of microbubbles, using real-time contrast harmonic imaging in breast tumors.
MATERIAL AND METHODS: A total of 29 female patients (mean age 54 years) with either clear malignant or benign findings in the breast or axilla were included. Contrast harmonic imaging (CHI US) was performed with a Philips iU22 using an L9-3 MHz linear probe, especially designed for this purpose. A low mechanical index (0.06-0.07) was used to avoid massive destruction of the microbubbles. A dose of 2.4 ml of Sono Vue was first infused intravenously over 1 min with an infusion pump. After 10 min, the same dose was injected as a bolus over 2 s, followed by a flush of 10 ml of saline solution. Contrast uptakes by the tumors were recorded 2 min from the moment of injection, with both methods for each patient.
RESULTS: Bolus administration of contrast agent provided a sharply demarcated enhancement and wash-out pattern for all lesions. The continuous infusion of the same contrast agent failed to show any wash-in/wash-out or time-to-peak/peak intensity phenomena in all cases.
CONCLUSION: CEUS using real-time harmonic imaging in order to evaluate breast tumors should be performed with bolus administration of contrast agent in order to achieve better intensity/time curve outcomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19634024     DOI: 10.1080/02841850903085576

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  8 in total

1.  High-resolution, high-contrast ultrasound imaging using a prototype dual-frequency transducer: in vitro and in vivo studies.

Authors:  Ryan Gessner; Marc Lukacs; Mike Lee; Emmanuel Cherin; F Stuart Foster; Paul A Dayton
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2010-08       Impact factor: 2.725

Review 2.  Advances in molecular imaging with ultrasound.

Authors:  Ryan Gessner; Paul A Dayton
Journal:  Mol Imaging       Date:  2010-06       Impact factor: 4.488

3.  Predictive model for contrast-enhanced ultrasound of the breast: Is it feasible in malignant risk assessment of breast imaging reporting and data system 4 lesions?

Authors:  Jun Luo; Ji-Dong Chen; Qing Chen; Lin-Xian Yue; Guo Zhou; Cheng Lan; Yi Li; Chi-Hua Wu; Jing-Qiao Lu
Journal:  World J Radiol       Date:  2016-06-28

4.  Super-Resolution Ultrasound Imaging of Skeletal Muscle Microvascular Dysfunction in an Animal Model of Type 2 Diabetes.

Authors:  Debabrata Ghosh; Jun Peng; Katherine Brown; Shashank Sirsi; Chieko Mineo; Philip W Shaul; Kenneth Hoyt
Journal:  J Ultrasound Med       Date:  2019-01-31       Impact factor: 2.153

5.  Diagnostic value of contrast-enhanced ultrasound parametric imaging in breast tumors.

Authors:  Zhang Yuan; Jiang Quan; Zhang Yunxiao; Chen Jian; He Zhu; Gong Liping
Journal:  J Breast Cancer       Date:  2013-06-28       Impact factor: 3.588

6.  Prediction of treatment responses to neoadjuvant chemotherapy in breast cancer using contrast-enhanced ultrasound.

Authors:  Yunxia Huang; Jian Le; Aiyu Miao; Wenxiang Zhi; Fen Wang; Yaling Chen; Shichong Zhou; Cai Chang
Journal:  Gland Surg       Date:  2021-04

7.  Breast contrast-enhanced ultrasound: is a scoring system feasible? A preliminary study in China.

Authors:  Xiaoyun Xiao; Bing Ou; Haiyun Yang; Huan Wu; Baoming Luo
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

8.  Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer.

Authors:  Anne Rix; Marion Piepenbrock; Barbara Flege; Saskia von Stillfried; Patrick Koczera; Tatjana Opacic; Nina Simons; Peter Boor; Sven Thoröe-Boveleth; Roel Deckers; Jan-Niklas May; Twan Lammers; Georg Schmitz; Elmar Stickeler; Fabian Kiessling
Journal:  Theranostics       Date:  2021-09-21       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.